NO180166C - Pyrrolidin- og tiazolidinderivater samt medikamenter inneholdende forbindelsene - Google Patents

Pyrrolidin- og tiazolidinderivater samt medikamenter inneholdende forbindelsene

Info

Publication number
NO180166C
NO180166C NO934300A NO934300A NO180166C NO 180166 C NO180166 C NO 180166C NO 934300 A NO934300 A NO 934300A NO 934300 A NO934300 A NO 934300A NO 180166 C NO180166 C NO 180166C
Authority
NO
Norway
Prior art keywords
compounds
pyrrolidine
well
medicaments containing
thiazolidine derivatives
Prior art date
Application number
NO934300A
Other languages
English (en)
Other versions
NO180166B (no
NO934300D0 (no
NO934300L (no
Inventor
Marc Capet
Claude Cotrel
Claude Guyon
Michel Joannic
Franco Manfre
Gerard Roussel
Marie-Christine Dubroeucq
Michel Cheve
Gilles Dutruc-Rosset
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of NO934300D0 publication Critical patent/NO934300D0/no
Publication of NO934300L publication Critical patent/NO934300L/no
Publication of NO180166B publication Critical patent/NO180166B/no
Publication of NO180166C publication Critical patent/NO180166C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06017—Dipeptides with the first amino acid being neutral and aliphatic
    • C07K5/06026—Dipeptides with the first amino acid being neutral and aliphatic the side chain containing 0 or 1 carbon atom, i.e. Gly or Ala
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/06—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with radicals, containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Neurology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Psychology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO934300A 1991-07-10 1993-11-26 Pyrrolidin- og tiazolidinderivater samt medikamenter inneholdende forbindelsene NO180166C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9108675A FR2678938B1 (fr) 1991-07-10 1991-07-10 Derives de pyrrolidine, leur preparation et les medicaments les contenant.
PCT/FR1992/000626 WO1993001167A1 (fr) 1991-07-10 1992-07-03 Derives de pyrrolidine et thiazolidine, leur preparation et les medicaments les contenant

Publications (4)

Publication Number Publication Date
NO934300D0 NO934300D0 (no) 1993-11-26
NO934300L NO934300L (no) 1993-11-26
NO180166B NO180166B (no) 1996-11-18
NO180166C true NO180166C (no) 1997-02-26

Family

ID=9414933

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934300A NO180166C (no) 1991-07-10 1993-11-26 Pyrrolidin- og tiazolidinderivater samt medikamenter inneholdende forbindelsene

Country Status (23)

Country Link
US (1) US5610144A (no)
EP (2) EP0527069A1 (no)
JP (1) JP3034043B2 (no)
KR (1) KR100234927B1 (no)
AT (1) ATE120732T1 (no)
AU (1) AU662345B2 (no)
BR (1) BR1100717A (no)
CA (1) CA2102697C (no)
CZ (1) CZ283602B6 (no)
DE (1) DE69201956T2 (no)
DK (1) DK0593639T3 (no)
ES (1) ES2071510T3 (no)
FI (1) FI105190B (no)
FR (1) FR2678938B1 (no)
HU (1) HU223470B1 (no)
IE (1) IE66331B1 (no)
NO (1) NO180166C (no)
NZ (1) NZ243514A (no)
PL (5) PL171112B1 (no)
RU (1) RU2118316C1 (no)
SK (1) SK1694A3 (no)
WO (1) WO1993001167A1 (no)
ZA (1) ZA925128B (no)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2695641B1 (fr) * 1992-09-11 1994-11-25 Rhone Poulenc Rorer Sa (Amino-3 phényl)-1 éthanesulfonate d'hydroquinine optiquement actif, sa préparation et son utilisation.
FR2700166B1 (fr) * 1993-01-07 1995-02-17 Rhone Poulenc Rorer Sa Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
FR2700168B1 (fr) * 1993-01-07 1995-02-03 Rhone Poulenc Rorer Sa Dérivés de thiazolidine, leur préparation et les médicaments les contenant.
FR2700167B1 (fr) * 1993-01-07 1995-02-03 Rhone Poulenc Rorer Sa Dérivés de pyrrolidine et thiazolidine, leur préparation et les médicaments les contenant.
FR2700165B1 (fr) * 1993-01-07 1995-02-17 Rhone Poulenc Rorer Sa Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
US5744485A (en) * 1994-03-25 1998-04-28 Vertex Pharmaceuticals Incorporated Carbamates and ureas as modifiers of multi-drug resistance
FR2721314B1 (fr) * 1994-06-20 1996-07-19 Rhone Poulenc Rorer Sa Dérivés de pyrrolidine, leur préparation et les médicaments les contenant.
FR2721608B1 (fr) * 1994-06-22 1996-07-19 Rhone Poulenc Rorer Sa Dérivés de thiazolidine, leur préparation et les médicaments les contenant.
FR2734724B1 (fr) * 1995-06-01 1997-07-04 Rhone Poulenc Rorer Sa Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'alcoolisme
CA2223625C (en) 1995-06-06 2003-06-03 Pfizer Inc. Substituted n-(indole-2-carbonyl-) amides and derivatives as glycogen phosphorylase inhibitors
MY114711A (en) * 1995-06-06 2002-12-31 Pfizer Substituted n-(indole-2-carbonyl)-b-alanmamides and derivatives as antidiabetic agents
FR2744361B1 (fr) * 1996-02-07 1998-02-27 Rhone Poulenc Rorer Sa Application de derives de pyrrolidine a la preparation de medicaments destines au traitement de l'abus de drogues ou de substances donnant lieu a des pharmacomanies ou a un usage excessif
TW442449B (en) 1996-07-04 2001-06-23 Hoechst Ag Process for preparing 1,2-dichloroethane by direct chlorination
DE19816880A1 (de) * 1998-04-17 1999-10-21 Boehringer Ingelheim Pharma Neue Diphenyl-substituierte 5-Ring-Heterocyclen, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel
EP1296949A2 (en) * 2000-06-21 2003-04-02 Bristol-Myers Squibb Pharma Company Piperidine amides as modulators of chemokine receptor activity
US6277877B1 (en) * 2000-08-15 2001-08-21 Pfizer, Inc. Substituted n-(indole-2-carbonyl)glycinamides and derivates as glycogen phosphorylase inhibitors
CN101307046B (zh) 2000-10-30 2012-08-15 詹森药业有限公司 三肽酶抑制剂
US7105556B2 (en) 2001-05-30 2006-09-12 Bristol-Myers Squibb Company Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method
PL374732A1 (en) * 2002-09-19 2005-10-31 Abbott Laboratories Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv)
US7238724B2 (en) 2002-09-19 2007-07-03 Abbott Laboratories Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
US7262207B2 (en) 2002-09-19 2007-08-28 Abbott Laboratories Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
US6846836B2 (en) 2003-04-18 2005-01-25 Bristol-Myers Squibb Company N-substituted phenylurea inhibitors of mitochondrial F1F0 ATP hydrolase
US7230002B2 (en) 2004-02-03 2007-06-12 Glenmark Pharmaceuticals Ltd. Dipeptidyl peptidase IV inhibitors; processes for their preparation and compositions thereof
AU2005220705A1 (en) * 2004-02-11 2005-09-22 The Ohio State University Research Foundation Analogs exhibiting inhibition of cell proliferation, methods of making, and uses thereof
WO2007086584A1 (ja) * 2006-01-30 2007-08-02 Meiji Seika Kaisha, Ltd. 新規ＦａｂＫおよびＦａｂＩ／Ｋ阻害剤
JP2009544621A (ja) * 2006-07-20 2009-12-17 アボット・ラボラトリーズ （２ｓ，５ｒ）−５−エチニル−１−｛ｎ−（４−メチル−１−（４−カルボキシ−ピリジン−２−イル）ピペリジン−４−イル）グリシル｝ピロリジン−２−カルボニトリルの合成
US8247438B2 (en) 2008-02-27 2012-08-21 Neuropill, Inc. Methods for treating schizophrenia
CN101407502B (zh) * 2008-11-21 2010-12-22 南京大学 一类n-(叔丁氧基羰基)噻唑烷酸类化合物及其制法和用途
DE102009004204A1 (de) * 2009-01-09 2010-07-15 Christian-Albrechts-Universität Zu Kiel Verfahren zur verbesserten Bioaktivierung von Arzneistoffen
PT2513053T (pt) * 2009-12-18 2018-01-09 Ogeda Sa Derivados de ácido carboxílico de pirrolidina como agonistas de recetor 43 acoplado à proteína g (gpr43), composição farmacêutica e métodos para utilização no tratamento de distúrbios metabólicos
WO2012036962A2 (en) 2010-09-13 2012-03-22 Amylin Pharmaceuticals, Inc. C-terminal amidation of polypeptides
ES2755332T3 (es) 2013-11-27 2020-04-22 Epics Therapeutics Compuestos, composición farmacéutica y métodos para su uso en el tratamiento de la inflamación
CN107430127B (zh) 2015-01-24 2020-08-28 中央研究院 癌症标记及其使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH362072A (de) * 1957-03-19 1962-05-31 Ciba Geigy Verfahren zur Herstellung neuer Acylpiperidine
US4499102A (en) * 1979-12-13 1985-02-12 Santen Pharmaceutical Co., Ltd. Thiazolidine and pyrrolidine compounds and pharmaceutical compositions containing them
EP0059966B1 (en) * 1981-03-09 1986-08-13 Merck & Co. Inc. Substituted thiazolidine carboxylic acid analogs and derivatives as antihypertensives
DE3332633A1 (de) * 1983-09-09 1985-04-04 Luitpold-Werk Chemisch-pharmazeutische Fabrik GmbH & Co, 8000 München Substituierte carbonsaeurederivate, verfahren zu ihrer herstellung, und arzneimittel
CA2022346A1 (en) * 1989-08-04 1991-02-05 Mitsubishi Chemical Corporation 1-phenylalkyl-3-phenylurea derivatives
US5258405A (en) * 1990-03-12 1993-11-02 Yamanouchi Pharmaceutical Co., Ltd. Urea derivatives and salts thereof in method for inhibiting the ACAT enzyme

Also Published As

Publication number Publication date
HUT70403A (en) 1995-10-30
CZ283602B6 (cs) 1998-05-13
EP0593639B1 (fr) 1995-04-05
FI940072A0 (fi) 1994-01-07
PL171094B1 (pl) 1997-03-28
NZ243514A (en) 1995-03-28
CA2102697A1 (fr) 1993-01-11
PL171095B1 (pl) 1997-03-28
PL171112B1 (pl) 1997-03-28
IE66331B1 (en) 1995-12-27
NO180166B (no) 1996-11-18
AU662345B2 (en) 1995-08-31
DE69201956D1 (de) 1995-05-11
EP0593639A1 (fr) 1994-04-27
SK1694A3 (en) 1994-12-07
ES2071510T3 (es) 1995-06-16
US5610144A (en) 1997-03-11
HU223470B1 (hu) 2004-07-28
JPH06509331A (ja) 1994-10-20
ZA925128B (en) 1993-04-28
IE922244A1 (en) 1993-01-13
BR1100717A (pt) 2000-03-14
FR2678938A1 (fr) 1993-01-15
EP0527069A1 (fr) 1993-02-10
FI940072A (fi) 1994-01-07
JP3034043B2 (ja) 2000-04-17
KR100234927B1 (ko) 2000-02-01
DK0593639T3 (da) 1995-07-03
PL171333B1 (pl) 1997-04-30
RU2118316C1 (ru) 1998-08-27
AU2327592A (en) 1993-02-11
NO934300D0 (no) 1993-11-26
ATE120732T1 (de) 1995-04-15
FR2678938B1 (fr) 1993-10-08
HU9400061D0 (en) 1994-05-30
CA2102697C (fr) 2003-09-30
FI105190B (fi) 2000-06-30
DE69201956T2 (de) 1995-11-30
NO934300L (no) 1993-11-26
PL171054B1 (pl) 1997-02-28
WO1993001167A1 (fr) 1993-01-21
CZ4994A3 (en) 1994-04-13

Similar Documents

Publication Publication Date Title
NO180166C (no) Pyrrolidin- og tiazolidinderivater samt medikamenter inneholdende forbindelsene
NO921835L (no) Fremgangsmaate for fremstilling av amidinofenylalaninderivat samt anvendelse derav
FI914928A (fi) Hydroximetyl (metylencyklopentyl) puriner och -pyrimidiner.
ATE84413T1 (de) Arzneimittel, enthaltend di-tert.butylhydroxyphenyl-derivatesowie neue derivate.
DK0509398T3 (da) Quinoxaliner, fremgangsmåder til deres fremstilling samt deres anvendelse
NZ217650A (en) Quinoline derivatives and pharmaceutical compositions
ES2091310T3 (es) Nuevos derivados de la n-benzoil-prolina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
AU654125B2 (en) Novel diphenylthyazole derivative
FI915245A0 (fi) 7-acyl-3-(substitueradkarbamoyloxi) cefemfoereningar samt foerfarande foer framstaellning av dessa.
DK284588A (da) Beta-lactam-forbindelser, deres fremstilling og anvendelse som laegemidler.
ES2098517T3 (es) Derivados de 1,2,4-tiadiazino(3,4-b)benzotiazol, su preparacion y los medicamentos que los contienen.
NO910309L (no) Fremgangsmaate for fremstilling samt anvedelse av et nytt antibiotisk deoksymulundocandin.
YU47723B (sh) Postupak za dobivanje derivata 2-imino-3-heterocikloalkilbenzotiazolina
ES2093051T3 (es) Purinil- y pirimidil-tetrahidrofuranos.
ATE119394T1 (de) Verwendung von myricetin-3-0-beta-d-glucuronid als arzneimittel.
DK656889A (da) Azabicykliske derivater
ATE60048T1 (de) Aminoverbindungen und diese enthaltende fungizide.
FI882388A0 (fi) 4-substituerad 10-cyanmetylenpyrrolo /4,3-e/benzoazepin.
ES2032573T3 (es) Procedimiento de preparacion de derivados de 4,4-dimetil-tetrahidropir-2-ona.
ZA917001B (en) Medicaments containing substituted 2-cyclohexene derivates and their use for the control of diseases

Legal Events

Date Code Title Description
MK1K Patent expired